Abstract: The invention is an antenna for use with an implantable microdevice, such as a microstimulator or microsensor, having a dipole antenna that is formed by ceramic processes on the inner or outer surface of the ceramic case of the microdevice. The antenna receives data transmitted from an external device, and transmits data to an external device. A dipole antenna may be formed from two radiating elements separated by an insulating material. A tuning circuit comprising capacitors and/or inductors is used to obtain resonance in the dipole antenna. In a preferred embodiment, the antenna is formed of a biocompatible material by applying a metal-containing paste to the ceramic case of the microdevice and thermally processing it.

Abstract: An implantable medical device (IMD) system includes an IMD, a transceiver antenna lead for the IMD, and a wireless therapy delivery transponder or probe that is remotely activated by the IMD via the transceiver antenna lead. The IMD and the wireless probe communicate using wireless RF-based transponder techniques. The wireless probe includes a capacitor that is charged when the IMD emits an appropriate electromagnetic field from the transceiver antenna lead. The wireless probe delivers electrical therapy in the form of electrical pulses from the capacitor in response to RF activation signals emitted by the IMD via the transceiver antenna lead.

Abstract: An exemplary method includes an implantable stimulator simultaneously applying stimulation current to a stimulation site within a patient via at least one stimulating electrode and compensating current via one or more additional electrodes of opposite polarity as the at least one stimulating electrode and dynamically adjusting the simultaneously applied compensating current as a function of a stimulation level of the stimulation current by increasing a stimulation level of the compensating current if the stimulation level of the stimulation current decreases and decreasing the stimulation level of the compensating current if the stimulation level of the stimulation current increases. Corresponding methods and systems are also disclosed.

Abstract: An implantable medical device includes cardiac pacing functions. In order to reduce ventricular pacing, various modes are employed that tolerate missed ventricular beats, provide backup pacing and maintain overall AV synchrony. Upon the occurrence of a PVC, A-A timing is modified so that resultant V-V intervals are appropriate and ventricular pacing is avoided.

Abstract: Receiver-stimulators comprise a nearly isotropic transducer assembly, demodulator circuitry, and at least two tissue contacting electrodes. Use of near isotropic transducers allows the devices to be implanted with less concern regarding the orientation relative to an acoustic energy source. Transducers or transducer elements having relatively small sizes, typically less than ½ the wavelength of the acoustic source, enhance isotropy. The use of single crystal piezoelectric materials enhance sensitivity.

Abstract: A cardiac lead comprising a lead body extending from a proximal end portion to a distal end portion; a cardiac electrode disposed along the lead body; and a coating associated with at least a portion of the electrode, the coating comprises a conductive polymer.

Abstract: Methods of using electrodes to obtain physiological location motion data are provided. Embodiments of the methods include producing an electrode from a broadcasting electrode that is proximal to the physiological location of interest and detecting a change in an induced electric potential at a receiving electrode to obtain the motion data of interest. Also provided are systems and components thereof, e.g., programming, for practicing methods according to embodiments of the invention.

Abstract: A defibrillator includes a module having a portion of the high-voltage components of the defibrillator attached to a substrate and encased in a dielectric material. In one embodiment the defibrillating shock is delivered by a high voltage H-bridge circuit which utilizes four controllably switched semiconductor devices such as IGBTs.

Abstract: Apparatus is provided, including a control unit configured for implantation in a body of a subject. An electrode is coupled to the control unit. The control unit is configured to receive programming instructions via the electrode and to drive current into tissue of the subject via the electrode. Other embodiments are also described.

Abstract: Implantable systems, and methods for use therewith, are provided for using an implantable sensor for detecting body position and/or body movement, and using what is learned therefrom to improve accuracy of an implantable sensor that is sensitive to at least one of body position and/or body movement. Also provided are implantable systems, and methods for use therewith, that detect body position and/or body movement in order to monitor a condition and/or detect specific episodes. Other embodiments are also provided.

Abstract: A pump has an elongated shell with a generally elliptical shape, an outer convex surface and an inner concave surface. A peripheral side edge located between the inner and outer surfaces terminates in a bead edge. A flexible airtight membrane has a membrane edge bonded to the outer shell surface adjacent to the bead edge. Preforming the membrane edge looped with a maximum linear span of curvature that is greater than a maximal transverse linear extent of the bead edge, membrane operational wear during inflation and deflation cycles is reduced in the region around the bead edge. A process of forming a blood pump with a membrane preform is also provided.

Abstract: Various powering devices are provided for transferring and/or generating energy from numerous sources to a communicating member implanted in a patient. The energy transferred to or generated by the communicating member can be used to provide power to an implantable restriction system configured to form a restriction in a pathway.

Abstract: An elastic structure is introduced percutaneously into the left ventricle and attached to the walls of the ventricle. Over time the structure bonds firmly to the walls via scar tissue formation. The structure helps the ventricle expand and fill with blood during the diastolic period while having little affect on systolic performance. The structure also strengthens the ventricular walls and limits the effects of congestive heart failure, as the maximum expansion of the support structure is limited by flexible or elastic members.

Abstract: An apparatus and a system can chronically and automatically measure a physiologic parameter associated with the high pressure side of the vasculature and/or regulate blood pressure based upon the measured parameter. The apparatus may be made up of a transducer, a baroreflex activation device having one or more electrodes, and a lead having two or more conductors. The system can measure a physiologic parameter and selectively administer a therapy, such as, for example, electro-stimulation of baroreceptors, based upon the measurement. The transducer for measuring the physiologic parameter can be chronically implanted in the high-pressure side of the vasculature. The implantation method may include intravascularly positioning the transducer in the external carotid artery in such a way that the transducer is first introduced into the arterial vasculature through the superior thyroid artery.

Abstract: Embodiments include electrical leads and methods of using electrical leads that may be implantable and are controllably secured to target tissue. Some embodiments may include radially extending tissue engaging members that may serve as electrodes and which may be retracted if necessary to remove embodiments of an electrical lead.

Abstract: A tissue stimulation system and computer software and method of monitoring a neurostimulation lead having a plurality of electrodes implanted within a patient (e.g., adjacent the spinal cord) is provided. Neurostimulation lead models are provided, each of which includes estimated electrical parameter data (e.g., electrical field potential data) corresponding to a predetermined position of the neurostimulation lead. Electrical energy is transmitted to or from the electrodes, and electrical parameter data (e.g., electrical field potential data) is measured in response to the transmitted electrical energy. The measured electrical parameter data is compared with the estimated electrical parameter data of each of the neurostimulation lead models, and a position of the neurostimulation lead is determined based on the comparison.

Abstract: Methods and kits are provided for determining an increased likelihood of the occurrence of a cardiac arrhythmia, myocardial ischemia, congestive heart failure and other diseased conditions of the heart. The methods and kits comprise measuring serum NGF levels in a subject and detecting increases in NGF levels over baseline. The methods may further comprise initiating preventive therapy in response to a detected increase in serum NGF levels.

Abstract: A power source providing electric power to subcutaneously implanted devices capture mechanical energy from the expansion and contraction of a cross-section of a blood vessel during a systolic-diastolic blood pressure cycle include a mechano-electric transducer assembly mechanically coupled to involuntarily moving tissue. The transducer includes a deformable inner element and a substantially rigid outer structure positioned outward of the elastic inner element. A transducer element disposed between the substantially rigid outer structure and the inner element is operable to generate electric energy and output the electric energy to a pair of output terminals. A deformable biocompatible envelope substantially surrounds the outer structure, the inner element and the transducer element.

Abstract: Apparatus is provided including first and second chambers, adapted to be in fluid communication with first and second volumes of oxygenated blood of a subject, respectively, the first and second chambers having first and second surfaces, respectively. A third surface is adapted to apply an elastically-derived force, at least a first and second portions of the third surface in mechanical communication with, respectively, the first and second surfaces, during at least a portion of a cardiac cycle. A pressure-sensitive valve is coupled between the first and second chambers, the valve adapted: (a) to be in an open position during at least a portion of systole, such that the first chamber is in fluid communication with the second chamber; and (b) to be in a substantially closed position during diastole, such that the first chamber is substantially not in fluid communication with the second chamber. Other embodiments are also described.

Abstract: A laryngeal stimulation system including a sensor for detecting an occurrence of a respiratory signal in a subject and a laryngeal stimulator adapted for coupling to a laryngeal muscle and operable to stimulate the laryngeal muscle in response to the sensor detecting the occurrence of the respiratory signal is provided. A method for laryngeal stimulation including detecting an occurrence of a respiratory signal in a subject and then stimulating a laryngeal muscle in response to detecting the occurrence of the respiratory signal is also provided.